Mannkind

Welcome To The Mannkind HUB On AGORACOM Edit this title from the Fast Facts Section

Home Videos Research Press Release Q&A Discussion

about 12 years ago

Market currents Part 2:

Monday, August 27, 4:20 PM One possible partner for MannKind (MNKD +9% would be Pfizer (PFE -0.5%), according to a Motley Fool article published over the weekend. Not only does MNKD desperately need a partner, but PFE is also in equal need of a new blockbuster drug. So, with MNKD's Afrezza near complete on its clinical trials, the synergies appear, on the surface at least, to be a natural fit.

http://seekingalpha.com/currents/post/509231